F.I.T. Investment JSC

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000FIT6
VND
5,030.00
-370 (-6.85%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company has a low Debt to Equity ratio (avg) at times

 
2

Low Debt Company with Strong Long Term Fundamental Strength

3

With ROE of 2.97%, it has a very attractive valuation with a 0.40 Price to Book Value

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND 1,835,638 Million (Small Cap)

stock-summary
P/E

13.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.64

stock-summary
Return on Equity

2.90%

stock-summary
Price to Book

0.47

Revenue and Profits:
Net Sales:
515,309 Million
(Quarterly Results - Mar 2025)
Net Profit:
37,461 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
5.23%
0%
5.23%
6 Months
12.78%
0%
12.78%
1 Year
19.48%
0%
19.48%
2 Years
9.11%
0%
9.11%
3 Years
20.33%
0%
20.33%
4 Years
-60.42%
0%
-60.42%
5 Years
-46.38%
0%
-46.38%

F.I.T. Investment JSC for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
13.39%
EBIT Growth (5y)
48.57%
EBIT to Interest (avg)
0.50
Debt to EBITDA (avg)
0.34
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.36
Tax Ratio
30.32%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
1.04%
ROE (avg)
4.00%
Valuation key factors
Factor
Value
P/E Ratio
13
Industry P/E
Price to Book Value
0.40
EV to EBIT
-13.01
EV to EBITDA
-3.40
EV to Capital Employed
-0.51
EV to Sales
-0.37
PEG Ratio
0.02
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
2.97%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is -24.05% vs 70.46% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2025 is 55.15% vs -13.83% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "515,308.60",
          "val2": "678,485.10",
          "chgp": "-24.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "114,523.30",
          "val2": "49,616.20",
          "chgp": "130.82%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "18,418.90",
          "val2": "15,218.60",
          "chgp": "21.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "37,461.50",
          "val2": "24,144.80",
          "chgp": "55.15%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "71.00%",
          "val2": "15.80%",
          "chgp": "5.52%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 11.91% vs -8.94% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 327.38% vs -208.41% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,953,658.10",
          "val2": "1,745,767.60",
          "chgp": "11.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "181,068.90",
          "val2": "176,677.80",
          "chgp": "2.49%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "53,562.00",
          "val2": "69,858.10",
          "chgp": "-23.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "176,503.30",
          "val2": "-77,624.50",
          "chgp": "327.38%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "20.10%",
          "val2": "15.70%",
          "chgp": "0.44%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Mar'25 - QoQstock-summary
Mar'25
Dec'24
Change(%)
Net Sales
515,308.60
678,485.10
-24.05%
Operating Profit (PBDIT) excl Other Income
114,523.30
49,616.20
130.82%
Interest
18,418.90
15,218.60
21.03%
Exceptional Items
0.00
0.00
Consolidate Net Profit
37,461.50
24,144.80
55.15%
Operating Profit Margin (Excl OI)
71.00%
15.80%
5.52%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2025 is -24.05% vs 70.46% in Dec 2024

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Mar 2025 is 55.15% vs -13.83% in Dec 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
1,953,658.10
1,745,767.60
11.91%
Operating Profit (PBDIT) excl Other Income
181,068.90
176,677.80
2.49%
Interest
53,562.00
69,858.10
-23.33%
Exceptional Items
0.00
0.00
Consolidate Net Profit
176,503.30
-77,624.50
327.38%
Operating Profit Margin (Excl OI)
20.10%
15.70%
0.44%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 11.91% vs -8.94% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 327.38% vs -208.41% in Dec 2023

stock-summaryCompany CV
About F.I.T. Investment JSC stock-summary
stock-summary
F.I.T. Investment JSC
Pharmaceuticals & Biotechnology
F.I.T Investment Joint Stock Company is a Vietnam-based company engaged in the investment industry. The Company provides consulting services, including corporate brand development consulting services, personal finance services, insurance brokerage services and real estate services. Its investment activities include financial investment activities, real estate investment activities, investments into subsidiaries and affiliates. The Company operates in five segments: listed corporation investment opportunity consulting services, service rendering, real estate trading, real estate management and leasing, and other activities. During the year ended December 31, 2012, 53% of the Company's net revenue came from the service rendering segment.
Company Coordinates stock-summary
Company Details
Level 16 - Center Bldg -Hapulco Cmplx, No 1 Ngyn Hy Tng St,Thanh Xuan Trung Wrd, Thanh Xuan District, HANOI None : None
stock-summary
Tel: 84 4 7309468884 24 73094688
stock-summary
Registrar Details